HilleVax Ownership | Who Owns HilleVax?

HilleVax Ownership Summary

HilleVax is owned by 26.12% institutional investors, 16.85% insiders, and 57.03% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 21.24% of HLVX shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.52% of its assets in HilleVax shares.

HLVX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	HilleVax	26.12%	16.85%	57.03%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Frazier life sciences management	10.62M	21.24%	$15.39M
Takeda pharmaceutical	6.72M	13.62%	$13.92M
Tang capital management	4.92M	9.96%	$10.18M
Blackrock funding, inc. /de	2.16M	4.38%	$4.48M
Blackrock	2.09M	4.31%	$30.23M
Franklin resources	1.96M	3.96%	$4.05M
Deerfield management company, l.p. (series c)	1.88M	3.77%	$2.73M
Carlyle group	1.84M	3.72%	$3.82M
Vanguard group	1.61M	3.25%	$3.32M
Balyasny asset management	1.00M	2.03%	$2.08M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Takeda pharmaceutical	6.72M	52.40%	$13.92M
Qiming u.s. ventures management	372.62K	1.51%	$771.31K
Stepstone group lp	826.57K	1.50%	$1.71M
Frazier life sciences management	10.62M	0.70%	$15.39M
Tang capital management	4.92M	0.67%	$10.18M
Stonepine capital management	132.35K	0.22%	$273.96K
Samsara biocapital	399.64K	0.10%	$579.47K
Carlyle group	1.84M	0.09%	$3.82M
Deerfield management company, l.p. (series c)	1.88M	0.05%	$2.73M
Bml capital management	20.76K	0.03%	$42.97K

Top Buyers

Holder	Shares	% Assets	Change
Goldman sachs group	699.35K	0.00%	453.02K
Blackrock	2.09M	0.00%	290.33K
Jpmorgan chase	207.15K	-	193.12K
Stonepine capital management	132.35K	0.22%	132.35K
Deutsche bank ag\	420.55K	0.00%	104.00K

Top Sellers

Holder	Shares	% Assets	Change
T. rowe price investment management	-	-	-3.48M
Vr adviser	-	-	-2.08M
Deep track capital, lp	-	-	-1.83M
Janus henderson group	-	-	-1.12M
Braidwell lp	-	-	-1.06M

New Positions

Holder	Shares	% Assets	Change	Value
Stonepine capital management	132.35K	0.22%	132.35K	$273.96K
Aqr capital management	24.27K	0.00%	24.27K	$50.23K
Intech investment management	12.65K	0.00%	12.65K	$26.18K
Bnp paribas arbitrage, snc	4.36K	-	4.36K	$9.03K
Principal securities	752.00	-	752.00	$1.56K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-4.00
Quarry lp	-61.00
Fortitude family office	-385.00
Cornerstone planning group	-400.00
Quest partners	-832.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	4	-94.74%	13,054,137	-69.53%	26	0.35%	-	-100.00%	1	-93.33%
Dec 31, 2024	45	-43.04%	18,234,599	-56.32%	36	0.52%	26	-46.94%	7	-61.11%
Sep 30, 2024	78	-13.33%	35,023,214	-9.66%	70	1.11%	49	-24.62%	18	50.00%
Jun 30, 2024	90	13.92%	38,767,553	4.27%	79	1.31%	65	62.50%	12	-47.83%
Mar 31, 2024	79	16.18%	37,178,279	4.62%	78	0.94%	40	-11.11%	23	91.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Franklin Biotechnology Discv A(acc)USD	1.26M	2.52%	-
T. Rowe Price US Small-Cap Core Equity	806.64K	1.62%	173.56K
iShares Russell 2000 ETF	794.55K	1.59%	390.00
Vanguard Total Stock Mkt Idx Inv	758.06K	1.51%	-
Franklin Biotechnology Discovery A	691.36K	1.38%	-
T. Rowe Price U.S. SC Value Eq Tr-Z	439.91K	0.88%	3.33K
T. Rowe Price U.S. SC Core Eq Tr-Z	394.48K	0.79%	89.26K
Vanguard Institutional Extnd Mkt Idx Tr	387.79K	0.77%	-
Xtrackers S&P 500 Swap ETF 1C	298.90K	0.60%	-
Fidelity Small Cap Index	294.25K	0.59%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 11, 2025	HERSHBERG ROBERT	See Remarks	Sell	$21.00K
Feb 04, 2025	HERSHBERG ROBERT	See Remarks	Sell	$27.66K
Feb 11, 2025	Maltbie Shane	Chief Financial Officer	Sell	$7.66K
Feb 04, 2025	Maltbie Shane	Chief Financial Officer	Sell	$7.46K
May 22, 2024	Kohli Aditya	-	Sell	$88.37K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	4
2024 Q2	1	9
2024 Q1	1	14
2023 Q4	-	5
2023 Q2	-	-

HLVX Ownership FAQ

Who Owns HilleVax?

HilleVax shareholders are primarily institutional investors at 26.12%, followed by 16.85% insiders and 57.03% retail investors. The average institutional ownership in HilleVax's industry, Biotech Stocks , is 63.96%, which HilleVax falls below.

Who owns the most shares of HilleVax?

HilleVax’s largest shareholders are Frazier life sciences management (10.62M shares, 21.24%), Takeda pharmaceutical (6.72M shares, 13.62%), and Tang capital management (4.92M shares, 9.96%). Together, they hold 44.82% of HilleVax’s total shares outstanding.

Does Blackrock own HilleVax?

Yes, BlackRock owns 4.31% of HilleVax, totaling 2.09M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.23M$. In the last quarter, BlackRock increased its holdings by 290.33K shares, a 16.13% change.

Who is HilleVax’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is HilleVax’s biggest shareholder by percentage of total assets invested, with 52.40% of its assets in 6.72M HilleVax shares, valued at 13.92M$.

Who is the top mutual fund holder of HilleVax shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of HilleVax shares, with 2.52% of its total shares outstanding invested in 1.26M HilleVax shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools